Not recruiting
Amyotrophic lateral sclerosis
Not recruitingStudy on the Safety and Efficacy of ARGX-119 for Adults with Amyotrophic Lateral Sclerosis (ALS)
Investigational
Study on the Safety and Efficacy of ARGX-119 for Adults with Amyotrophic Lateral Sclerosis (ALS)
Investigational
- Disease:Amyotrophic lateral sclerosis
- Substances:Humanised IgG1 monoclonal antibody against muscle specific kinase
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Humanised IgG1 monoclonal antibody against muscle specific kinase



